Zobrazeno 1 - 8 of 8 pro vyhledávání: '"Morris DN"'
1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
2
Akademický článek
Association Between Neighborhood Context and Psychotropic Polypharmacy Use Among High-Need Children.
Autor: Thomas KC; Division of Pharmaceutical Outcomes and Policy, University of North Carolina at Chapel Hill (UNC) Eshelman School of Pharmacy, Chapel Hill (Thomas, Annis, Davis, Hughes); UNC Cecil G. Sheps Center for Health Services Research, Chapel Hill (Thomas, Hughes); Departments of Pediatrics (deJong, Christian) and Psychiatry (Christian), UNC School of Medicine, Chapel Hill; Parent Advisory Group, UNC Eshelman School of Pharmacy, Chapel Hill (B. A. Prichard, J. R. Prichard, Allen, Gettinger, Morris, Eaker)., Annis IE; Division of Pharmaceutical Outcomes and Policy, University of North Carolina at Chapel Hill (UNC) Eshelman School of Pharmacy, Chapel Hill (Thomas, Annis, Davis, Hughes); UNC Cecil G. Sheps Center for Health Services Research, Chapel Hill (Thomas, Hughes); Departments of Pediatrics (deJong, Christian) and Psychiatry (Christian), UNC School of Medicine, Chapel Hill; Parent Advisory Group, UNC Eshelman School of Pharmacy, Chapel Hill (B. A. Prichard, J. R. Prichard, Allen, Gettinger, Morris, Eaker)., deJong NA; Division of Pharmaceutical Outcomes and Policy, University of North Carolina at Chapel Hill (UNC) Eshelman School of Pharmacy, Chapel Hill (Thomas, Annis, Davis, Hughes); UNC Cecil G. Sheps Center for Health Services Research, Chapel Hill (Thomas, Hughes); Departments of Pediatrics (deJong, Christian) and Psychiatry (Christian), UNC School of Medicine, Chapel Hill; Parent Advisory Group, UNC Eshelman School of Pharmacy, Chapel Hill (B. A. Prichard, J. R. Prichard, Allen, Gettinger, Morris, Eaker)., Christian RB; Division of Pharmaceutical Outcomes and Policy, University of North Carolina at Chapel Hill (UNC) Eshelman School of Pharmacy, Chapel Hill (Thomas, Annis, Davis, Hughes); UNC Cecil G. Sheps Center for Health Services Research, Chapel Hill (Thomas, Hughes); Departments of Pediatrics (deJong, Christian) and Psychiatry (Christian), UNC School of Medicine, Chapel Hill; Parent Advisory Group, UNC Eshelman School of Pharmacy, Chapel Hill (B. A. Prichard, J. R. Prichard, Allen, Gettinger, Morris, Eaker)., Davis SA; Division of Pharmaceutical Outcomes and Policy, University of North Carolina at Chapel Hill (UNC) Eshelman School of Pharmacy, Chapel Hill (Thomas, Annis, Davis, Hughes); UNC Cecil G. Sheps Center for Health Services Research, Chapel Hill (Thomas, Hughes); Departments of Pediatrics (deJong, Christian) and Psychiatry (Christian), UNC School of Medicine, Chapel Hill; Parent Advisory Group, UNC Eshelman School of Pharmacy, Chapel Hill (B. A. Prichard, J. R. Prichard, Allen, Gettinger, Morris, Eaker)., Hughes PM; Division of Pharmaceutical Outcomes and Policy, University of North Carolina at Chapel Hill (UNC) Eshelman School of Pharmacy, Chapel Hill (Thomas, Annis, Davis, Hughes); UNC Cecil G. Sheps Center for Health Services Research, Chapel Hill (Thomas, Hughes); Departments of Pediatrics (deJong, Christian) and Psychiatry (Christian), UNC School of Medicine, Chapel Hill; Parent Advisory Group, UNC Eshelman School of Pharmacy, Chapel Hill (B. A. Prichard, J. R. Prichard, Allen, Gettinger, Morris, Eaker)., Prichard BA; Division of Pharmaceutical Outcomes and Policy, University of North Carolina at Chapel Hill (UNC) Eshelman School of Pharmacy, Chapel Hill (Thomas, Annis, Davis, Hughes); UNC Cecil G. Sheps Center for Health Services Research, Chapel Hill (Thomas, Hughes); Departments of Pediatrics (deJong, Christian) and Psychiatry (Christian), UNC School of Medicine, Chapel Hill; Parent Advisory Group, UNC Eshelman School of Pharmacy, Chapel Hill (B. A. Prichard, J. R. Prichard, Allen, Gettinger, Morris, Eaker)., Prichard JR; Division of Pharmaceutical Outcomes and Policy, University of North Carolina at Chapel Hill (UNC) Eshelman School of Pharmacy, Chapel Hill (Thomas, Annis, Davis, Hughes); UNC Cecil G. Sheps Center for Health Services Research, Chapel Hill (Thomas, Hughes); Departments of Pediatrics (deJong, Christian) and Psychiatry (Christian), UNC School of Medicine, Chapel Hill; Parent Advisory Group, UNC Eshelman School of Pharmacy, Chapel Hill (B. A. Prichard, J. R. Prichard, Allen, Gettinger, Morris, Eaker)., Allen PS; Division of Pharmaceutical Outcomes and Policy, University of North Carolina at Chapel Hill (UNC) Eshelman School of Pharmacy, Chapel Hill (Thomas, Annis, Davis, Hughes); UNC Cecil G. Sheps Center for Health Services Research, Chapel Hill (Thomas, Hughes); Departments of Pediatrics (deJong, Christian) and Psychiatry (Christian), UNC School of Medicine, Chapel Hill; Parent Advisory Group, UNC Eshelman School of Pharmacy, Chapel Hill (B. A. Prichard, J. R. Prichard, Allen, Gettinger, Morris, Eaker)., Gettinger JS; Division of Pharmaceutical Outcomes and Policy, University of North Carolina at Chapel Hill (UNC) Eshelman School of Pharmacy, Chapel Hill (Thomas, Annis, Davis, Hughes); UNC Cecil G. Sheps Center for Health Services Research, Chapel Hill (Thomas, Hughes); Departments of Pediatrics (deJong, Christian) and Psychiatry (Christian), UNC School of Medicine, Chapel Hill; Parent Advisory Group, UNC Eshelman School of Pharmacy, Chapel Hill (B. A. Prichard, J. R. Prichard, Allen, Gettinger, Morris, Eaker)., Morris DN; Division of Pharmaceutical Outcomes and Policy, University of North Carolina at Chapel Hill (UNC) Eshelman School of Pharmacy, Chapel Hill (Thomas, Annis, Davis, Hughes); UNC Cecil G. Sheps Center for Health Services Research, Chapel Hill (Thomas, Hughes); Departments of Pediatrics (deJong, Christian) and Psychiatry (Christian), UNC School of Medicine, Chapel Hill; Parent Advisory Group, UNC Eshelman School of Pharmacy, Chapel Hill (B. A. Prichard, J. R. Prichard, Allen, Gettinger, Morris, Eaker)., Eaker KB; Division of Pharmaceutical Outcomes and Policy, University of North Carolina at Chapel Hill (UNC) Eshelman School of Pharmacy, Chapel Hill (Thomas, Annis, Davis, Hughes); UNC Cecil G. Sheps Center for Health Services Research, Chapel Hill (Thomas, Hughes); Departments of Pediatrics (deJong, Christian) and Psychiatry (Christian), UNC School of Medicine, Chapel Hill; Parent Advisory Group, UNC Eshelman School of Pharmacy, Chapel Hill (B. A. Prichard, J. R. Prichard, Allen, Gettinger, Morris, Eaker).
Publikováno v: Psychiatric services (Washington, D.C.) [Psychiatr Serv] 2024 Sep 11, pp. appips20230639. Date of Electronic Publication: 2024 Sep 11.
Zobrazit plný text záznamu
3
Akademický článek
Teaching of drug disposition using physiologically based pharmacokinetic modeling software: GastroPlus as an educational tool.
Autor: Morningstar-Kywi N; Department of Pharmacology and Pharmaceutical Sciences, University of Southern California Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, Los Angeles, California, United States.; Simulations Plus, Inc., Lancaster, California, United States., Morris DN; Simulations Plus, Inc., Lancaster, California, United States., Romero RM; Department of Pharmacology and Pharmaceutical Sciences, University of Southern California Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, Los Angeles, California, United States., Haworth IS; Department of Pharmacology and Pharmaceutical Sciences, University of Southern California Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, Los Angeles, California, United States.
Publikováno v: Advances in physiology education [Adv Physiol Educ] 2023 Dec 01; Vol. 47 (4), pp. 718-725. Date of Electronic Publication: 2023 Jul 20.
Zobrazit plný text záznamu
4
Akademický článek
Pharmacokinetics and Biochemical Efficacy of an α 1 -Proteinase Inhibitor (Aralast NP) in α 1 -Antitrypsin Deficiency: a Cross-Product Retrospective Comparability Analysis.
Autor: Li Z; Takeda Development Center Americas, Inc., 650 East Kendall Street, Cambridge, MA, 02142, USA. zhaoyang.li@takeda.com., Franke RM; Cognigen, a SimulationsPlus Company, Buffalo, NY, USA., Morris DN; Cognigen, a SimulationsPlus Company, Buffalo, NY, USA., Yel L; Takeda Development Center Americas, Inc., 650 East Kendall Street, Cambridge, MA, 02142, USA.
Publikováno v: Pulmonary therapy [Pulm Ther] 2022 Sep; Vol. 8 (3), pp. 311-326. Date of Electronic Publication: 2022 Aug 24.
Zobrazit plný text záznamu
5
Akademický článek
Design and tests of prospective property predictions for novel antimalarial 2-aminopropylaminoquinolones.
Autor: Clark RD; Simulations Plus, Inc., 42505 10th Street West, Lancaster, CA, 93534-7059, USA. bob@simulations-plus.com., Morris DN; Cognigen Corporation, a Simulations Plus Company, Buffalo, NY, USA., Chinigo G; Kalexsyn, Inc., Kalamazoo, MI, USA.; Pfizer Inc., Groton, CT, USA., Lawless MS; Simulations Plus, Inc., 42505 10th Street West, Lancaster, CA, 93534-7059, USA., Prudhomme J; Department of Molecular, Cell and Systems Biology, University of California, Riverside, CA, USA., Le Roch KG; Department of Molecular, Cell and Systems Biology, University of California, Riverside, CA, USA., Lafuente MJ; Tres Cantos Medicines Development Campus-Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain., Ferrer S; Tres Cantos Medicines Development Campus-Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain., Gamo FJ; Tres Cantos Medicines Development Campus-Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain., Gadwood R; Kalexsyn, Inc., Kalamazoo, MI, USA., Woltosz WS; Simulations Plus, Inc., 42505 10th Street West, Lancaster, CA, 93534-7059, USA.
Publikováno v: Journal of computer-aided molecular design [J Comput Aided Mol Des] 2020 Nov; Vol. 34 (11), pp. 1117-1132. Date of Electronic Publication: 2020 Aug 24.
Zobrazit plný text záznamu
6
Akademický článek
Population pharmacokinetic modelling and simulation of fremanezumab in healthy subjects and patients with migraine.
Autor: Fiedler-Kelly JB; Cognigen Corporation (a SimulationsPlus company), Buffalo, NY, USA., Cohen-Barak O; Teva Pharmaceutical Industries Ltd., Netanya, Israel., Morris DN; Gilead Sciences, Inc., Foster City, CA, USA., Ludwig E; Cognigen Corporation (a SimulationsPlus company), Buffalo, NY, USA., Rasamoelisolo M; Teva Pharmaceutical Industries Ltd., Frazer, PA, USA., Shen H; Teva Pharmaceutical Industries Ltd., Frazer, PA, USA., Levi M; Teva Pharmaceutical Industries Ltd., Frazer, PA, USA.
Publikováno v: British journal of clinical pharmacology [Br J Clin Pharmacol] 2019 Dec; Vol. 85 (12), pp. 2721-2733. Date of Electronic Publication: 2019 Dec 09.
Zobrazit plný text záznamu
7
Akademický článek
Spirituality in occupational therapy: do we practice what we teach?
Autor: Morris DN; College of Health Professions, Florida Gulf Coast University, 10501 FGCU Blvd. S., Fort Myers, FL, 33965, USA, dmorris@fgcu.edu., Stecher J, Briggs-Peppler KM, Chittenden CM, Rubira J, Wismer LK
Publikováno v: Journal of religion and health [J Relig Health] 2014 Feb; Vol. 53 (1), pp. 27-36.
Zobrazit plný text záznamu
8
Akademický článek
A fluorescent probe for the active site of bovine trypsin.
Autor: Russo SF, Morris DN
Publikováno v: Physiological chemistry and physics and medical NMR [Physiol Chem Phys Med NMR] 1983; Vol. 15 (3), pp. 223-7.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje